kalcipos-d forte 500 mg/800 iu chewable tablets
mylan ire healthcare limited - calcium; cholecalciferol - chewable tablet - 500 mg/800 international unit(s) - calcium, combinations with vitamin d and/or other drugs
kalcipos-d forte 500 mg/800 iu film-coated tablets
mylan ire healthcare limited - calcium; cholecalciferol - film-coated tablet - 500 mg/800 international unit(s) - calcium, combinations with vitamin d and/or other drugs
tambocor 100 mg tablets
mylan ire healthcare limited - flecainide acetate - tablet - 100 milligram(s) - antiarrhythmics, class ic; flecainide
tambocor 50 mg tablets
mylan ire healthcare limited - flecainide acetate - tablet - 50 milligram(s) - antiarrhythmics, class ic; flecainide
desunin 1000 iu tablets
mylan ire healthcare limited - colecalciferol - tablet - 1000 international unit(s) - vitamin a and d, incl. combinations of the two
desunin 2000 iu tablets
mylan ire healthcare limited - colecalciferol - tablet - 2000 international unit(s) - vitamin a and d, incl. combinations of the two
desunin 4000 iu tablets
mylan ire healthcare limited - colecalciferol concentrate - tablet - 4000 international unit(s) - vitamin a and d, incl. combinations of the two
desunin 800 iu tablets
mylan ire healthcare limited - colecalciferol - tablet - 800 international unit(s) - vitamin d and analogues; colecalciferol
dona 1500 mg powder for oral solution
lexon (uk) ltd - glucosamine sulfate - powder for oral solution - 1500 milligram(s) - other antiinflammatory and antirheumatic agents, non-steroids; glucosamine
dovprela (previously pretomanid fgk)
mylan ire healthcare limited - pretomanid - tuberculosis, multidrug-resistant - antimycobacterials - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb).consideration should be given to official guidance on the appropriate use of antibacterial agents.